LIVIVO - Search results -

Search results

Result 1 - 10 of total 30

Search options

Article ; Online: Practice of Cardiology during COVID 19 pandemic. Recommendations of the Mexican Cardiology Community.

Sierra-Fernández, Carlos R / Alcocer-Gamba, Marco A / Buendía-Hernández, Alfonso

Archivos de cardiologia de Mexico

2020 Volume 90, Issue Supl, Page(s) 5–6

Title translation	La práctica de la Cardiología ante la pandemia por COVID-19. Recomendaciones de la comunidad cardiológica mexicana.
MeSH term(s)	COVID-19 ; Cardiology/organization & administration ; Coronavirus Infections/epidemiology ; Humans ; Mexico/epidemiology ; Pandemics ; Pneumonia, Viral/epidemiology
Keywords	covid19
Language	English
Publishing date	2020-06-10
Publishing country	Mexico
Document type	Editorial
ISSN	1665-1731
ISSN (online)	1665-1731
DOI	10.24875/ACM.M20000072
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: A cross-sectional study on the prevalence of cardiovascular disease in elderly patients with long-term type 2 diabetes mellitus mainly attended in private clinics in Mexico. The CAPTURE study.

Arenas-León, José L / Morales-Villegas, Enrique C / Cardona-Muñoz, Ernesto G / Alcocer-Gamba, Marco A / Ramirez-Contreras, Juan P / Contreras-Sandoval, Aleida Y / González-Galvez, Guillermo

Diabetology & metabolic syndrome

2023 Volume 15, Issue 1, Page(s) 258

Abstract: Background: To estimate the contemporary prevalence of established cardiovascular disease (CVD) in adults with type 2 diabetes (T2D) in Mexico.: Methods: CAPTURE was a multinational, non-interventional, cross-sectional study across 13 countries from ... ...

Abstract	Background: To estimate the contemporary prevalence of established cardiovascular disease (CVD) in adults with type 2 diabetes (T2D) in Mexico. Methods: CAPTURE was a multinational, non-interventional, cross-sectional study across 13 countries from five continents. Standardized demographic and clinical data were collected from adults with T2D attending a single routine healthcare visit in primary or specialized care between December 2018 and September 2019. Data from Mexico are analyzed in this study. Results: Of the 9,823 patients included in the CAPTURE study, 820 (8.3%) participants were from Mexico, mainly attended in private centers (29.3% in 6 specialized diabetes treatment centers and 70.7% in 26 primary care centers). The median age was 63.0 years, 52.6% were women, the duration of diabetes was 11.8 years and the average HbA1c 7.5%. The weighted prevalence [95% CI] of CVD and atherosclerotic CVD was 36.9% [34.1-39.6] and 29.5% [26.7-32.3], respectively. Additionally, the prevalence of coronary heart disease, heart failure, peripheral arterial disease and cerebrovascular disease was 23.1% [20.6-25-7], 8.4% [6.8-10.0], 5.0% [3.5-6.5] and 3.9% [2.6-5.2], respectively. Glucose lowering drugs were used in 88.5% of patients, being metformin the most commonly drug used (79.4%), followed by sulfonylureas (26.3%). SGLT-2 inhibitors and GLP1 receptor agonists were used in 15.5% and 3.9%, respectively. Conclusions: In Mexico, nearly four out of ten patients with T2D mainly attended in private centers have CVD, particularly atherosclerotic CVD. Most patients were not taking glucose lowering drugs with proven CV benefit.
Language	English
Publishing date	2023-12-07
Publishing country	England
Document type	Journal Article
ZDB-ID	2518786-7
ISSN	1758-5996
ISSN	1758-5996
DOI	10.1186/s13098-023-01231-6
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: La práctica de la Cardiología ante la pandemia por COVID-19. Recomendaciones de la comunidad cardiológica mexicana./ Practice of Cardiology during COVID 19 pandemic. Recommendations of the Mexican Cardiology Community

Sierra-Fernández, Carlos R / Alcocer-Gamba, Marco A / Buendía-Hernández, Alfonso

Arch Cardiol Mex

Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #32523148
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article: La práctica de la Cardiología ante la pandemia por COVID-19. Recomendaciones de la comunidad cardiológica mexicana

Sierra-Fernández, Carlos R. / Alcocer-Gamba, Marco A. / Buendía-Hernández, Alfonso

Arch Cardiol Mex

Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #603307
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: The SARS-CoV-2 (COVID-19) coronavirus pandemic: current situation and implications for Mexico.

Escudero, Xavier / Guarner, Jeannette / Galindo-Fraga, Arturo / Escudero-Salamanca, Mara / Alcocer-Gamba, Marco A / Del-Río, Carlos

Archivos de cardiologia de Mexico

2020 Volume 90, Issue Supl, Page(s) 7–14

Abstract: The Coronavirus pandemic (COVID-19) is one of the most devastating in this century. It originated in China in December 2019 caused by the SARS-Cov-2 virus, and in less than a month it had been classified as an "International Public Health Emergency". To ... ...

Title translation	La pandemia de Coronavirus SARS-CoV-2 (COVID-19): Situación actual e implicaciones para México.
Abstract	The Coronavirus pandemic (COVID-19) is one of the most devastating in this century. It originated in China in December 2019 caused by the SARS-Cov-2 virus, and in less than a month it had been classified as an "International Public Health Emergency". To date there are nearly 3 million people infected and more than 250,000 deaths caused by the disease worldwide. Initially it affects the respiratory tract with atypical pneumonia and in severe cases it produces systemic inflammation with cytokine storm that can cause rapid deterioration with circulatory and respiratory failure, coagulopathy and a lethality rate of approximately 7%. In Mexico, the first case was detected in February 2020, and to date there are 26,616 confirmed cases and 2,961 deaths throughout the country. The low number of diagnostic tests conducted in our country clearly underestimates the real incidence and impact of the disease. The most affected groups are those with risk factors such as age over 60, presence of hypertension, diabetes or cardiovascular disease. Of the confirmed cases, 15% are healthcare workers. There is no specific treatment or vaccine yet, so it is important to have hygiene, social isolation and personal protection measures. Health, social and economic consequences could have great impact in the near future.
MeSH term(s)	Age Factors ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques/statistics & numerical data ; Coronavirus Infections/diagnosis ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Health Personnel/statistics & numerical data ; Humans ; Incidence ; Mexico/epidemiology ; Pandemics/prevention & control ; Personal Protective Equipment ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/prevention & control ; Risk Factors
Keywords	covid19
Language	English
Publishing date	2020-06-10
Publishing country	Mexico
Document type	Journal Article
ISSN	1665-1731
ISSN (online)	1665-1731
DOI	10.24875/ACM.M20000064
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Return to exercise after COVID-19. Statement of the Mexican Society of Cardiology

Cerón-Enriquez, Norma / García-Saldivia, Marianna A / Lara-Vargas, Jorge A / Núñez-Urquiza, Juan P / Alonso-Sánchez, J Jesús / Silva-Torres, J Jesús / Pérez-Gámez, Juan C / Pacheco-Beltrán, Nancy / Alcocer-Gamba, Marco A

Archivos de cardiologia de Mexico

2021 Volume 91, Issue Suplemento COVID, Page(s) 102–109

Abstract: The coronavirus disease 2019 (COVID-19) was declared a pandemic on March 11, 2020; one consequence has been the increase in sedentary lifestyle and reduction of sports activity. Exercise benefits the immune defense system especially in older adults; it ... ...

Title translation	Retorno al ejercicio después de COVID-19. Posicionamiento de la Sociedad Mexicana de Cardiología
Abstract	The coronavirus disease 2019 (COVID-19) was declared a pandemic on March 11, 2020; one consequence has been the increase in sedentary lifestyle and reduction of sports activity. Exercise benefits the immune defense system especially in older adults; it is recommended to keep a distance of 1.5 meters between people, and if walking or jogging is carried out, the space must be up to 5 and 10 meters respectively. The reported cases are mostly mild up to 80% and can be critical in up to 4.7%; the risk factors are well known, hypertension, diabetes and previous heart disease. Severe or critical cases present as symptoms of acute respiratory distress syndrome, and in the case of cardiovascular disease, they mainly occur as myopericarditis, acute coronary syndromes, cardiogenic shock, thrombotic events, among others. Returning to exercise after recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is always recommended, however it will depend on the clinical picture what measures should be taken prior to its onset, and it is in moderate cases and especially in the severe ones where the evaluation and prescription prior to returning to exercise or sport should be guided by medical personnel experts in cardiopulmonary rehabilitation, especially in athletes.
MeSH term(s)	COVID-19 ; Cardiac Rehabilitation ; Cardiology ; Humans ; Mexico ; Pandemics ; Return to Sport
Language	Spanish
Publishing date	2021-12-20
Publishing country	Mexico
Document type	Journal Article
ZDB-ID	2059019-2
ISSN	1665-1731 ; 1665-1731
ISSN (online)	1665-1731
ISSN	1665-1731
DOI	10.24875/ACM.20000507
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Documento de consenso sobre el uso de iSGLT2 en pacientes con enfermedad renal crónica y diabetes.

Correa-Rotter, Ricardo / Rosas-Guzmán, Juan / Méndez-Durán, Antonio / Sebastián-Díaz, Mario A / Díaz-Avendaño, Odette Del C / Mehta-Pravin, Roopa / Alcocer-Gamba, Marco A

Gaceta medica de Mexico

2021 Volume 158, Issue M2, Page(s) M1–M12

Abstract: La enfermedad renal crónica (ERC) del paciente diabético es frecuentemente una consecuencia directa de la diabetes mellitus (DM) de larga evolución y se la conoce como nefropatía diabética. En México cerca del 50% de los pacientes en terapia sustitutiva ... ...

Title translation	Consesus document in the use of SGLT inhibitors in patients with diabetes and chronic kidney disease.
Abstract	La enfermedad renal crónica (ERC) del paciente diabético es frecuentemente una consecuencia directa de la diabetes mellitus (DM) de larga evolución y se la conoce como nefropatía diabética. En México cerca del 50% de los pacientes en terapia sustitutiva de la función renal tienen ERC por DM, y este porcentaje podría aumentar en los próximos años. Nuevas opciones terapéuticas, combinadas con cambios en el estilo de vida, han mejorado el control de la glucemia y pueden contribuir sustancialmente a retrasar la aparición o la progresión a estadios avanzados de la ERC. Las sociedades científicas internacionales han elaborado guías clínicas para el diagnóstico y manejo de la nefropatía diabética, sin embargo, en algunos puntos estas recomendaciones no se adaptan a la realidad mexicana. Se presentan las conclusiones de un consenso realizado por especialistas mexicanos sobre diabetes y ERC, con especial énfasis en el uso de los inhibidores del cotransportador de sodio-glucosa. Chronic kidney disease (CKD) in the diabetic patient is mainly a consequence of long-term diabetes mellitus itself. In Mexico approximately 50% of patients on dialysis are diabetics and this will could increase in the coming years. New therapeutic options available, combined with lifestyle changes, have improved glycemic control and may contribute to delay the onset as well as the progression of CKD. International scientific societies have developed clinical guidelines for the diagnosis and management of CKD in diabetics, although in some points, these recommendations are not adapted to the Mexican reality. We hereby present the conclusions of the consensus reached by Mexican specialists on diabetic nephropathy.
MeSH term(s)	Diabetes Mellitus/epidemiology ; Humans ; Mexico/epidemiology ; Renal Dialysis ; Renal Insufficiency, Chronic/epidemiology ; Retrospective Studies
Language	English
Publishing date	2021-12-30
Publishing country	Mexico
Document type	Journal Article
ZDB-ID	425456-9
ISSN	0016-3813
ISSN	0016-3813
DOI	10.24875/GMM.M21000595
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.38: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: COVID-19 and the renin, angiotensin, aldosterone system. A complex relationship.

Alcocer-Díaz-Barreiro, Luis / Cossio-Aranda, Jorge / Verdejo-Paris, Juan / Odin-de-Los-Ríos, Manuel / Galván-Oseguera, Héctor / Álvarez-López, Humberto / Alcocer-Gamba, Marco A

Archivos de cardiologia de Mexico

2020 Volume 90, Issue Supl, Page(s) 19–25

Abstract: The COVID-19 pandemic has had major negative health, psychological, social and economic repercussions for individuals, families, communities, countries and for humanity in general. The interrelation with age and the presence of chronic non-communicable ... ...

Title translation	COVID-19 y el sistema renina, angiotensina, aldosterona. Una relación compleja.
Abstract	The COVID-19 pandemic has had major negative health, psychological, social and economic repercussions for individuals, families, communities, countries and for humanity in general. The interrelation with age and the presence of chronic non-communicable diseases (hypertension, diabetes, obesity, smoking) seems to go further than what would be explained by the prevalence and distribution of both. The drugs that act on the renin-angiotensin-aldosterone system are in many cases the backbone for the management of these diseases, it has been known for a long time that these drugs significantly increase the expression of receptors for angiotensin conversion enzyme type 2 in the lung tissue. This fact, together with the knowledge that the route of entry of the virus into the cell is precisely the ACE-2 receptor, initiated a hypothesis, based on very low-quality evidence, which quickly became generalized in the media, that the use of these drugs could be negative and that they should be interrupted immediately. The response of practically all Scientific Societies was almost immediate, with the precise indication that treatment with these drugs should not be discontinued, since the evidence of their usefulness is based on very solid and high-quality evidence. Simultaneously, a different hypothesis also appeared, also based on very preliminary evidence, that these drugs are not only harmful but also beneficial, however these medicaments are not yet accepted as agents for the prevention or treatment of this disease or its complications. This review reports current knowledge on the relationship between COVID-19 and SRAA.
MeSH term(s)	Animals ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Coronavirus Infections/virology ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Humans ; Pandemics ; Peptidyl-Dipeptidase A/metabolism ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/virology ; Renin-Angiotensin System/drug effects ; Renin-Angiotensin System/physiology ; Risk Factors
Chemical Substances	Peptidyl-Dipeptidase A (EC 3.4.15.1) ; angiotensin converting enzyme 2 (EC 3.4.17.-)
Keywords	covid19
Language	English
Publishing date	2020-05-06
Publishing country	Mexico
Document type	Journal Article ; Review
ISSN	1665-1731
ISSN (online)	1665-1731
DOI	10.24875/ACM.M20000063
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Care of acute coronary syndromes during the health contingency due to a SARS-CoV-2 outbreak.

Piña-Reyna, Yigal / García-Rincón, Andrés / Ortiz-Fernández P, Patricio H / Alcocer-Gamba, Marco A / Gutiérrez-Fajardo, Pedro / Merino-Rajme, José A / Reyes-Terán, Gustavo

Archivos de cardiologia de Mexico

2020 Volume 90, Issue Supl, Page(s) 33–35

Abstract: The communications accumulated in the last weeks make it clear that there is no agreement to define the best treatment strategy in patients with acute coronary syndrome (SICA). In patients presenting with an acute myocardial infarction with ST-segment ... ...

Title translation	Atención de los síndromes coronarios agudos durante la contingencia sanitaria por brote de SARS-CoV-2.
Abstract	The communications accumulated in the last weeks make it clear that there is no agreement to define the best treatment strategy in patients with acute coronary syndrome (SICA). In patients presenting with an acute myocardial infarction with ST-segment elevation (IAMCESST), it has been suggested to favor fibrinolysis (FL) over primary percutaneous coronary intervention (PCI), reserving ICP for cases of failed FL
MeSH term(s)	Acute Coronary Syndrome/physiopathology ; Acute Coronary Syndrome/therapy ; COVID-19 ; Cardiac Catheterization ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Disease Outbreaks ; Humans ; Mexico/epidemiology ; Non-ST Elevated Myocardial Infarction/physiopathology ; Non-ST Elevated Myocardial Infarction/therapy ; Pandemics/prevention & control ; Percutaneous Coronary Intervention/methods ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/prevention & control ; ST Elevation Myocardial Infarction/physiopathology ; ST Elevation Myocardial Infarction/therapy
Keywords	covid19
Language	English
Publishing date	2020-06-10
Publishing country	Mexico
Document type	Journal Article
ISSN	1665-1731
ISSN (online)	1665-1731
DOI	10.24875/ACM.M20000062
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Recommendations for the care of patients with heart failure and COVID-19.

Cigarroa-López, José A / Magaña-Serrano, José A / Álvarez-Sangabriel, Amada / Ruíz-Ruíz, Vicente / Chávez-Mendoza, Adolfo / Méndez-Ortíz, Arturo / León-González, Salvador / Guízar-Sánchez, Carlos / Gutiérrez-Fajardo, Pedro / Alcocer-Gamba, Marco A

Archivos de cardiologia de Mexico

2020 Volume 90, Issue Supl, Page(s) 26–32

Abstract: The COVID-19 pandemic decreed by the World Health Organization (WHO) since March 12, 2020 is wreaking havoc globally and it is a true economic, social and health challenge. Although the clinical manifestations of COVID-19 are respiratory symptoms, some ... ...

Title translation	Recomendaciones para la atención de pacientes con insuficiencia cardiaca y COVID-19.
Abstract	The COVID-19 pandemic decreed by the World Health Organization (WHO) since March 12, 2020 is wreaking havoc globally and it is a true economic, social and health challenge. Although the clinical manifestations of COVID-19 are respiratory symptoms, some patients also have cardiological symptoms. Among patients with cardiological conditions2 they represent a group of higher risk and, in fact, they are a particularly vulnerable group, due to their higher risk of contagion and greater severity in case of acquiring the disease1 those with heart failure (HF), including heart transplant (CT) and ventricular assists, as well as patients with pulmonary arterial hypertension (PAH). HF is the main chronic cardiovascular disease and patients in this group are the most vulnerable for the development of more serious clinical symptoms after suffering the infection, and to a greater extent cases with advanced HF3. In fact, HF is one of the most frequent complications in patients with COVID-194. Likewise, transplant patients who require immunosuppressants to avoid graft rejection, constitute a population especially susceptible to infection and to develop more serious processes. This situation has made the National Association of Cardiologists of Mexico (ANCAM) and the Mexican Society of Cardiology (SMC) together with their respective chapters, have prepared the following recommendations for medical personnel, who participate in the care of this special group of patients in the different clinical settings, who suffer or not, of COVID-19.
MeSH term(s)	COVID-19 ; Cardiovascular Diseases/physiopathology ; Cardiovascular Diseases/therapy ; Cardiovascular Diseases/virology ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Coronavirus Infections/virology ; Heart Failure/physiopathology ; Heart Failure/therapy ; Heart Failure/virology ; Humans ; Mexico ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/virology ; Risk Factors ; Severity of Illness Index
Keywords	covid19
Language	English
Publishing date	2020-06-10
Publishing country	Mexico
Document type	Journal Article
ISSN	1665-1731
ISSN (online)	1665-1731
DOI	10.24875/ACM.M20000060
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Kategorien

Inter-library loan at ZB MED

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Inter-library loan at ZB MED